ZIMV Stock Overview
Develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for ZIMV from our risk checks.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
ZimVie Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$13.14 |
| 52 Week High | US$22.40 |
| 52 Week Low | US$12.84 |
| Beta | 1.97 |
| 1 Month Change | -8.05% |
| 3 Month Change | -0.53% |
| 1 Year Change | -36.49% |
| 3 Year Change | -70.27% |
| 5 Year Change | n/a |
| Change since IPO | -53.07% |
Recent News & Updates
Recent updates
ZimVie: Guidance Suggests Company Fairly Valued At The Moment (Rating Downgrade)
Jun 04ZimVie: Shrinking Its Way To Profitability
Feb 12ZimVie Inc. (NASDAQ:ZIMV) Stock Catapults 93% Though Its Price And Business Still Lag The Industry
Dec 19
ZimVie Inc.'s (NASDAQ:ZIMV) Shares Bounce 27% But Its Business Still Trails The Industry
Apr 17ZimVie: Disappointing Guidance Prompts Caution
Aug 25ZimVie Q2 Non-GAAP EPS beats, revenue down Y/Y, guidance reduced
Aug 10ZimVie: Undervalued Spin-Off
Jul 05ZimVie: Spin-Off Of Dental And Spine Units Of Zimmer Biomet
Apr 23Shareholder Returns
| ZIMV | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -1.6% | 0.7% | 1.5% |
| 1Y | -36.5% | 13.0% | 22.4% |
Return vs Industry: ZIMV underperformed the US Medical Equipment industry which returned 12.9% over the past year.
Return vs Market: ZIMV underperformed the US Market which returned 22.2% over the past year.
Price Volatility
| ZIMV volatility | |
|---|---|
| ZIMV Average Weekly Movement | 3.7% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 18.0% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ZIMV has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ZIMV's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | 2,600 | Vafa Jamali | www.zimvie.com |
ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. It operates through The Dental Segment. The company offers dental implant systems; biomaterials; prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name.
ZimVie Inc. Fundamentals Summary
| ZIMV fundamental statistics | |
|---|---|
| Market cap | US$362.65m |
| Earnings (TTM) | -US$47.73m |
| Revenue (TTM) | US$451.29m |
0.8x
P/S Ratio-7.6x
P/E RatioIs ZIMV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZIMV income statement (TTM) | |
|---|---|
| Revenue | US$451.29m |
| Cost of Revenue | US$166.17m |
| Gross Profit | US$285.13m |
| Other Expenses | US$332.85m |
| Earnings | -US$47.73m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 26, 2025
| Earnings per share (EPS) | -1.73 |
| Gross Margin | 63.18% |
| Net Profit Margin | -10.58% |
| Debt/Equity Ratio | 54.2% |
How did ZIMV perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/16 12:04 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ZimVie Inc. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matt Miksic | Barclays |
| Matthew Miksic | Credit Suisse |
| null null | Equisights |